123 related articles for article (PubMed ID: 3703360)
1. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
3. [The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis].
Basso D; Fabris C; Del Favero G; Panucci A; Piccoli A; Plebani M; Pedrazzoli S; Baccaglini U; Lise M; Burlina A
Minerva Med; 1986 Apr; 77(16):613-6. PubMed ID: 3458035
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
[TBL] [Abstract][Full Text] [Related]
5. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
[TBL] [Abstract][Full Text] [Related]
7. Immunological diagnosis and prognosis of digestive tract cancer: some clinical considerations.
Zamcheck N
Ann Immunol (Paris); 1973 Nov; 124(4):635-40. PubMed ID: 4792503
[No Abstract] [Full Text] [Related]
8. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.
von Kleist S; Hesse Y; Kananeeh H
Anticancer Res; 1996; 16(4B):2325-31. PubMed ID: 8694564
[TBL] [Abstract][Full Text] [Related]
10. [Auxiliary value of TPA in diagnosing neoplastic diseases].
Mizushima Y; Nakamura F; Yokoyama A; Morikage T; Kawasaki S; Hoshino K; Maruyama M; Yamashita N; Yano S
Gan No Rinsho; 1986 Jun; 32(7):779-82. PubMed ID: 3735675
[TBL] [Abstract][Full Text] [Related]
11. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
12. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms].
Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P
Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188
[TBL] [Abstract][Full Text] [Related]
13. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
[TBL] [Abstract][Full Text] [Related]
14. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
[TBL] [Abstract][Full Text] [Related]
16. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
[TBL] [Abstract][Full Text] [Related]
17. [Carcinoembryonic antigen (CEA) in the digestive diseases (author's transl)].
Bekhti A; Collette J; Franchimont P
Arch Fr Mal App Dig; 1975; 64(5):399-406. PubMed ID: 1212060
[No Abstract] [Full Text] [Related]
18. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
Zamcheck N
Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
[No Abstract] [Full Text] [Related]
20. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
Lüthgens M; Schlegel G
Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
